Global X Genomics & Biotechnology ETF (GNOM) Holdings $10.23 -0.06 (-0.58%) (As of 11:34 AM ET) Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrends Top 42 GNOM HoldingsRankCompanyCurrent PriceWeightShares Held1NTRANatera$168.21-1.5%5.62%26,2202VCYTVeracyte$42.24-2.5%5.35%95,8723ARWRArrowhead Pharmaceuticals$22.27-0.4%4.56%156,1774TECHBio-Techne$75.27-1.2%4.42%44,8675QGENQiagen$45.34-0.1%4.38%73,8626BNTXBioNTech$117.39+2.8%4.29%28,033 Get the Latest News and Ratings for GNOM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Global X Genomics & Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. 7AAgilent Technologies$136.46-0.9%4.24%23,3868CRSPCRISPR Therapeutics$44.63+0.9%4.15%67,6329ILMNIllumina$143.12-0.9%4.12%21,76510BEAMBeam Therapeutics$28.58-1.2%3.92%105,55511SRPTSarepta Therapeutics$125.76-0.8%3.85%23,95312BMRNBioMarin Pharmaceutical$67.19+2.5%3.76%44,45613RAREUltragenyx Pharmaceutical$44.95-1.0%3.57%56,88514ALNYAlnylam Pharmaceuticals$246.58+1.1%3.44%10,55115LEGNLegend Biotech$34.68+5.1%3.26%70,78616MRNAModerna$40.76-2.6%3.21%58,27017RNAAvidity Biosciences$32.74-1.9%3.13%68,52518TXG10x Genomics$14.72-1.8%3.03%146,73819Genscript Biotech CorporationN/A2.72%1,542,51820NTLAIntellia Therapeutics$13.13-1.9%2.66%146,99121MYGNMyriad Genetics$13.82-2.1%2.40%128,71322CDNACareDx$22.14-3.2%2.26%72,69823RCKTRocket Pharmaceuticals$11.92+1.4%2.12%123,47424GILDGilead Sciences$92.80+0.8%2.11%17,83225VRTXVertex Pharmaceuticals$469.24+0.2%1.99%3,30926QUREuniQure$16.46-5.4%1.31%65,45227VIRVir Biotechnology$7.35-2.8%1.30%129,87528MRVIMaravai LifeSciences$5.81+3.9%1.27%171,40329PSTXPoseida Therapeutics$9.50-0.1%1.15%94,27830PACBPacific Biosciences of California$1.97-3.9%1.10%377,97331RGNXREGENXBIO$8.47-0.8%0.77%64,81832FLGTFulgent Genetics$19.44-1.1%0.74%28,72833VERVVerve Therapeutics$5.61+3.7%0.73%90,89734SGMOSangamo Therapeutics$2.82+6.4%0.72%289,64635ALLOAllogene Therapeutics$2.07+0.5%0.55%200,93736SANASana Biotechnology$1.91-2.6%0.53%177,16337TSVT2seventy bio$3.21-1.5%0.33%69,95638CRBUCaribou Biosciences$1.94+1.6%0.31%119,71439EDITEditas Medicine$1.52+2.7%0.30%118,62840LYELLyell Immunopharma$0.65-3.0%0.22%199,421Do this Before Elon’s Reveal on January 22nd (Ad)Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. 41CashN/A0.08%63,18742SCLXScilex$0.500.01%226,071 Geographic ExposureUnited States87.5%Switzerland4.0%Cayman Islands2.5%Currency ExposureUSD78.0%HKD2.5%Sector ExposureHealth Care65.4%Energy1.0%Industry ExposureBiotechnology32.2%Health Care Equipment & Supplies24.1%Health Care Providers & Services6.7%Life Sciences Tools & Services2.5%Renewable Energy1.0%SubIndustry ExposureBiotechnology31.6%Life Sciences Tools & Services24.4%Health Care Services6.7%Health Care Equipment2.2%Renewable Energy Equipment1.0% Related Companies and Tools Related Companies HRTS Holdings TARK Holdings BLCN Holdings EMXF Holdings SPC Holdings QQMG Holdings LEGR Holdings VPN Holdings EBIZ Holdings AGNG Holdings This page (NASDAQ:GNOM) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | Sponsored50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Genomics & Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X Genomics & Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
